Health
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study – Times of India
India News: Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant…
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study
- News
- India News
- Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study
Continue Reading
-
Noosa News17 hours agoQueensland weather forecast sees sunny weather for last week of winter
-
General19 hours agoFirst home buyers score early access to deposit scheme
-
Noosa News18 hours agoForum responds to urgent homelessness issues in Nambour
-
General17 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers